Renal ion channels in the control of blood pressure

肾离子通道控制血压

基本信息

  • 批准号:
    10585921
  • 负责人:
  • 金额:
    $ 57.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-01-15 至 2023-12-31
  • 项目状态:
    已结题

项目摘要

Project Summary Ion channels are well recognized as important therapeutic targets because they play a crucial role in controlling a very wide spectrum of physiological processes. Human genetic studies identified a number of mutations in the renal ion channels leading to renal pathophysiology and abnormal changes in blood pressure. Understanding the basic mechanisms of ion channel regulation in the kidney and how alterations of such regulatory networks lead to water and electrolyte imbalance is fundamentally important for understanding of the development of hypertension and designing new strategies for treating this devastating and costly disease. The PI's research group has made key contributions in revealing specific mechanisms controlling several ion channels in the kidney and their contribution to the development of hypertension. Given the strong historical precedent that exists for discovering and commercializing successful drugs that modulate the activity of sodium, calcium, or potassium channels, and considering the critical role of renal ion channels in the control of blood pressure, new generations of therapeutic agents are expected to result from targeting ion channels in the kidney. The central tenet of this proposal is that several types of transporters, specifically ENaC, Kcnj10/Kcn16, Trpc6, and Clcn6, work either individually or in complex, interdependent combinations to delicately modulate the pressure natriuresis relationship and control blood pressure, respectively. The channels listed above were selected because either human mutations were reported in genes encoding these channels, or they were identified by Genome Wide Association Studies as genes associated with blood pressure control. Genomic modulation of channels and their regulators will be performed in the Dahl Salt- Sensitive (SS) rat, a well characterized and established model, which shares many features with salt-sensitive hypertension in humans. SS rat has been an enormously useful model as it is naturally occurring and recapitulates the major phenotypes found in hypertensive African Americans. Importantly, the SS model has been amenable to robust, cutting-edge genetic approaches to successfully create multiple mutant models, which will be used in this study. Considering the availability of these unique genetic rat models and novel approaches developed in my laboratory, I will be able to systematically study critical changes in corresponding ion transport mechanisms and downstream signaling pathways in the setting of salt-induced hypertension. The overall goal of this R35 proposal is to understand the impact of specific human gene variations on ion channel function and contribute to our understanding of the role of renal ion channels in normal and pathophysiological control of blood pressure.
项目概要 离子通道被公认为重要的治疗靶点,因为它们在控制 非常广泛的生理过程。人类遗传学研究发现了许多突变 肾离子通道导致肾脏病理生理和血压异常变化。 了解肾脏离子通道调节的基本机制以及如何改变这种机制 调节网络导致水和电解质失衡对于理解 高血压的发展并设计治疗这种破坏性且代价高昂的疾病的新策略。 PI的研究小组在揭示控制多种离子的具体机制方面做出了关键贡献 肾脏中的通道及其对高血压发展的贡献。鉴于深厚的历史底蕴 发现调节活性的成功药物并将其商业化的先例 钠、钙或钾通道,并考虑肾离子通道在控制中的关键作用 血压,新一代治疗剂预计将通过靶向体内的离子通道而产生。 肾。该提案的中心原则是几种类型的转运蛋白,特别是 ENaC, Kcnj10/Kcn16、Trpc6 和 Clcn6 可以单独工作,也可以以复杂、相互依赖的组合方式发挥作用 分别微妙地调节压力尿钠关系和控制血压。这 选择上面列出的通道是因为编码这些通道的基因中报告了人类突变 通道,或者它们被全基因组关联研究鉴定为与血液相关的基因 压力控制。通道及其调节器的基因组调节将在达尔盐中进行 敏感 (SS) 大鼠,一种经过充分表征和建立的模型,与盐敏感大鼠具有许多共同特征 人类高血压。 SS 大鼠是一种非常有用的模型,因为它是自然发生的并且 概括了在高血压非裔美国人中发现的主要表型。重要的是,SS 模型具有 能够采用强大的、尖端的遗传方法来成功创建多个突变模型, 将在本研究中使用。考虑到这些独特的遗传大鼠模型和新颖的可用性 在我的实验室开发的方法中,我将能够系统地研究相应的关键变化 盐诱发高血压中的离子转运机制和下游信号通路。 该 R35 提案的总体目标是了解特定人类基因变异对离子的影响 通道功能,有助于我们了解肾离子通道在正常和正常情况下的作用 血压的病理生理控制。

项目成果

期刊论文数量(21)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Therapeutic effects of L-lysine in Dahl SS rats, a Model of Salt-Induced Hypertension.
L-赖氨酸对 Dahl SS 大鼠(盐诱发高血压模型)的治疗作用。
Effects of Potassium Supplementation and Kir7.1 Knockout on Renal Function During the Progression of Salt-Sensitive Hypertension.
钾补充剂和 Kir7.1 敲除对盐敏感性高血压进展期间肾功能的影响。
The Role of Angiotensin II in Glomerular Volume Dynamics and Podocyte Calcium Handling.
  • DOI:
    10.1038/s41598-017-00406-2
  • 发表时间:
    2017-03-22
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Ilatovskaya DV;Palygin O;Levchenko V;Endres BT;Staruschenko A
  • 通讯作者:
    Staruschenko A
Role of the Scaffold Protein MIM in the Actin-Dependent Regulation of Epithelial Sodium Channels (ENaC).
支架蛋白 MIM 在肌动蛋白依赖性上皮钠通道 (ENaC) 调节中的作用。
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    2
  • 作者:
    Shuyskiy,LS;Levchenko,VV;Negulyaev,YA;Staruschenko,AV;Ilatovskaya,DV
  • 通讯作者:
    Ilatovskaya,DV
Lack of Xdh Leads to Alterations in Renin-Angiotensin-Aldosterone System and Kidney Injury.
Xdh 缺乏会导致肾素-血管紧张素-醛固酮系统的改变和肾脏损伤。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALEXANDER STARUSCHENKO其他文献

ALEXANDER STARUSCHENKO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALEXANDER STARUSCHENKO', 18)}}的其他基金

Hypertension Scientific Sessions 2022
2022 年高血压科学会议
  • 批准号:
    10539105
  • 财政年份:
    2022
  • 资助金额:
    $ 57.02万
  • 项目类别:
Smart patch of podocytes
足细胞智能斑块
  • 批准号:
    10284970
  • 财政年份:
    2021
  • 资助金额:
    $ 57.02万
  • 项目类别:
Purinergic control of calcium flux in podocytes
足细胞钙流的嘌呤能控制
  • 批准号:
    9552989
  • 财政年份:
    2018
  • 资助金额:
    $ 57.02万
  • 项目类别:
Purinergic control of calcium flux in podocytes
足细胞钙流的嘌呤能控制
  • 批准号:
    10292941
  • 财政年份:
    2018
  • 资助金额:
    $ 57.02万
  • 项目类别:
Purinergic control of calcium flux in podocytes
足细胞钙流的嘌呤能控制
  • 批准号:
    10047722
  • 财政年份:
    2018
  • 资助金额:
    $ 57.02万
  • 项目类别:
Renal ion channels in the control of blood pressure
肾离子通道控制血压
  • 批准号:
    10559940
  • 财政年份:
    2017
  • 资助金额:
    $ 57.02万
  • 项目类别:
Renal ion channels in the control of blood pressure
肾离子通道控制血压
  • 批准号:
    9242307
  • 财政年份:
    2017
  • 资助金额:
    $ 57.02万
  • 项目类别:
Mechanisms and relevance of ENaC regulation by EGF and Rac1
EGF 和 Rac1 调节 ENaC 的机制和相关性
  • 批准号:
    8245462
  • 财政年份:
    2011
  • 资助金额:
    $ 57.02万
  • 项目类别:
Mechanisms and relevance of ENaC regulation by EGF and Rac1
EGF 和 Rac1 调节 ENaC 的机制和相关性
  • 批准号:
    8389894
  • 财政年份:
    2011
  • 资助金额:
    $ 57.02万
  • 项目类别:
Mechanisms and relevance of ENaC regulation by EGF and Rac1
EGF 和 Rac1 调节 ENaC 的机制和相关性
  • 批准号:
    8584320
  • 财政年份:
    2011
  • 资助金额:
    $ 57.02万
  • 项目类别:

相似海外基金

Developing Real-world Understanding of Medical Music therapy using the Electronic Health Record (DRUMMER)
使用电子健康记录 (DRUMMER) 培养对医学音乐治疗的真实理解
  • 批准号:
    10748859
  • 财政年份:
    2024
  • 资助金额:
    $ 57.02万
  • 项目类别:
DULCE (Diabetes InqUiry Through a Learning Collaborative Experience)
DULCE(通过学习协作体验进行糖尿病查询)
  • 批准号:
    10558119
  • 财政年份:
    2023
  • 资助金额:
    $ 57.02万
  • 项目类别:
Sleep and Cardiometabolic Subgroup Discovery and Risk Prediction in United States Adolescents and Young Adults: A Multi-Study Multi-Domain Analysis of NHANES and NSRR
美国青少年和年轻人的睡眠和心脏代谢亚组发现和风险预测:NHANES 和 NSRR 的多研究多领域分析
  • 批准号:
    10639360
  • 财政年份:
    2023
  • 资助金额:
    $ 57.02万
  • 项目类别:
Hospice exposure and utilization among older African Americans with ADRD and their decisional support persons
患有 ADRD 的老年非洲裔美国人及其决策支持人员的临终关怀暴露和利用
  • 批准号:
    10679558
  • 财政年份:
    2023
  • 资助金额:
    $ 57.02万
  • 项目类别:
The Role of Lipids in Alzheimer's Disease and Related Dementias among Black Americans: Examining Lifecouse Mechanisms
脂质在美国黑人阿尔茨海默病和相关痴呆中的作用:检查生命机制
  • 批准号:
    10643344
  • 财政年份:
    2023
  • 资助金额:
    $ 57.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了